FBLN2 and breast cancer: We therefore assessed FBLN2 expression in formalin-fixed histological sections from 65 breast cancer patients with invasive breast cancer with adjacent ductal carcinoma in situ (DCIS) as well as morphologically normal breast tissue to establish its role in disease progression to invasive cancer (Table 1).